Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 12, 20241 min read
Contact
Judy Fitzgerald
Research Advocate, Advocate for Vaccines to prevent women's cancers.
